ArriVent BioPharma Down Over 52%, on Track for Record Low Close and Record Percent Decrease -- Data Talk
Dow Jones2026/10/06 15:07ArriVent BioPharma, Inc. (AVBP) is currently at $13.49, down $14.97 or 52.61% --Would be new all-time closing low (Based on available data back to Jan. 26, 2024) --Would be largest percent decrease on record (Based on available data back to Jan. 26, 2024) --Currently down three of the past four days --Down 32.97% year-to-date; on pace for worst year on record (Based on available data back to Jan. 26, 2024) --Down 62.15% from its all-time closing high of $35.63 on Nov. 7, 2024 --Down 30.16% from 52 weeks ago (Oct. 7, 2025), when it closed at $19.31 --Down 61.18% from its 52-week closing high of $34.74 on June 30, 2026 --Would be a new 52-week closing low --Traded as low as $11.36; new all-time intraday low (Based on available data back to Jan. 26, 2024) --Down 60.08% at today's intraday low; largest intraday percent decrease on record (Based on available data back to Jan. 26, 2024) All data as of 11:05:10 AM ET Source: Dow Jones Market Data, FactSet (END) Dow Jones Newswires October 06, 2026 11:07 ET (15:07 GMT)
ArriVent BioPharma, Inc. (AVBP) is currently at $13.49, down $14.97 or 52.61%
--Would be new all-time closing low (Based on available data back to Jan. 26, 2024)
--Would be largest percent decrease on record (Based on available data back to Jan. 26, 2024)
--Currently down three of the past four days
--Down 32.97% year-to-date; on pace for worst year on record (Based on available data back to Jan. 26, 2024)
--Down 62.15% from its all-time closing high of $35.63 on Nov. 7, 2024
--Down 30.16% from 52 weeks ago (Oct. 7, 2025), when it closed at $19.31
--Down 61.18% from its 52-week closing high of $34.74 on June 30, 2026
--Would be a new 52-week closing low
--Traded as low as $11.36; new all-time intraday low (Based on available data back to Jan. 26, 2024)
--Down 60.08% at today's intraday low; largest intraday percent decrease on record (Based on available data back to Jan. 26, 2024)
All data as of 11:05:10 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
October 06, 2026 11:07 ET (15:07 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Jensen Huang's influence surpasses that of Nvidia— and that's exactly the problem
Jensen Huang has been the key driving force behind the massive expansion of AI infrastructure, with his personal credibility and authoritative decision-making deeply embedded in the narrative of the global tech market’s rise over the past three years. Now, as scandals emerge, Nvidia’s trading team is expected to become more conservative and slow down external financing commitments, which undoubtedly worsens the situation for neoclouds already facing tight funding.
Deutsche Bank made significant Q3 purchases of midstream AI application stocks: the three major cloud giants saw increased holdings, with Palantir (PLTR.US) and Salesforce (CRM.US) also favored.
Deutsche Bank has submitted its third quarter 13F holdings report for the period ending September 30, 2026.
Crypto prices
More
